Novel Hepatitis E Vaccine Protects for at Least a Decade
(MedPage Today) -- A three-dose vaccine regimen prevented hepatitis E virus (HEV) infections with high efficacy in adults over the course of 10 years, a phase III trial from China found. The HEV239 vaccine, sold under the name Hecolin outside... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - February 23, 2024 Category: Gastroenterology Source Type: news

World Cancer Day 2024
Cancer is a major contributor to global mortality, causing about 1 in every 6 deaths and affecting nearly every household (1). Globally, there were an estimated 20 million new cases of cancer and 9.7 million deaths from cancer in 2022. The cancer burden will increase by about 77% by 2050, further straining health systems, people and communities (2). In the WHO Eastern Mediterranean Region alone, more than 788 000 people were diagnosed with cancer in 2022. This number is projected to double to reach 1.57 million cases by 2045, because of population growth and, more importantly, the high prevalence of cancer risk factors in...
Source: WHO EMRO News - February 1, 2024 Category: Middle East Health Source Type: news

South Sudan: MSF Launches Mass Vaccination Campaign Amid Deadly Hepatitis E Outbreak
[MSF] Juba - In response to a deadly hepatitis E outbreak in South Sudan, MSF has launched a vaccination campaign in collaboration with the Ministry of Health to provide protection to women and girls of reproductive age, who are at greatest risk of death from the disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 30, 2024 Category: African Health Tags: Aid and Assistance East Africa Health and Medicine NGOs and Civil Society South Sudan Source Type: news

IIL launches first indigenous Hepatitis A vaccine
Priced at ?2,150 per dose, it is a two-dose vaccine in which the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose. The vaccine is also recommended for individuals who are at risk of exposure or travel to the regions with high hepatitis A prevalence. In addition to this people with occupational risk of infection and suffering from chronic liver diseases also need Hepatitis A vaccination. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2024 Category: Pharmaceuticals Source Type: news

Africa: The 3rd African Hepatitis Summit - 'Putting Africa On Track Towards Viral Hepatitis Elimination
[Africa CDC] Viral hepatitis remains a pressing concern, causing over 125,000 deaths annually in Africa alone, despite the existence of effective treatments and Hepatitis B vaccine. It is alarming that in Africa, over 70% of people living with viral hepatitis are unaware of their status and more than 90% lack necessary care. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 21, 2023 Category: African Health Tags: Africa Health and Medicine Source Type: news

When Should We Consider A Rickettsial Disease?
Discussion Rickettsioses are “small, obligate intracellular, gram-negative, aerobic coccobacillary α-proeobacteria” from the genuses Rickettsia, Anaplasma, Coxiella, Ehrlichia, and Orientia genuses. Often they cause limited health problems but can cause severe disease and death. They present with a fever and other non-specific signs and symptoms, usually with a rash and lymphadenopathy. Other problems can include: Cardiac – endocarditis, myocarditis, pericarditis Gastrointestinal – abdominal pain, acute abdomen, cholecystitis, hepatitis, pancreatitis Heme/Lymph – hemophagocytosis, lymph...
Source: PediatricEducation.org - December 18, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Africa: Alliance Introduces New Vaccine Programmes to Save More Lives and Support Child Health
[GAVI] Geneva -- Countries can now submit plans to introduce diphtheria, tetanus and pertussis (DTP)-containing vaccine boosters (DTP boosters) and the six-in-one hexavalent vaccine Gavi and partners are also working towards expanding the portfolio of offerings in 2024, including the hepatitis B birth dose and rabies vaccines Thabani Maphosa, Managing Director of Country Programmes Delivery, Gavi: "By continually expanding our vaccine portfolio, and targeting the children and communities most frequently left behind, we (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 5, 2023 Category: African Health Tags: Africa Children and Youth External Relations Health and Medicine International Organizations and Africa NGOs and Civil Society Source Type: news

Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic hepatitis B infection
Elecsys ® HBeAg quant is an immunoassay that can be used as an early marker of acute hepatitis B infection, as well as an indicator of chronic active hepatitis in combination with other laboratory results and clinical information.The single test will inform clinicians if treatment is required and regimens are working in conjunction with other diagnostic assays.Almost 300 million people globally have chronic hepatitis B, causing a significant burden to health systems as it puts patients at high risk of death from cirrhosis and liver cancer.1Basel, 27 November 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the la...
Source: Roche Media News - November 27, 2023 Category: Pharmaceuticals Source Type: news

How Late Can You Give Routine Newborn Care?
Discussion Routine newborn screening and treatment is focused on assisting the infant’s transition to extrauterine life, screening for health problems that may or may not be easily identifiable, and preventing acute or chronic health problems. Healthy infants begin with healthy pregnancies including risk factor assessment and screening of mothers. Such routine maternal screening and treatment does or may include glucose tolerance tests, ultrasound examinations, screenings for maternal blood type (with appropriate administration of Rho(D) immunoglobulin if appropriate), Hepatitis B, Neisseria gonorrhea, Chlamydia, Cyt...
Source: PediatricEducation.org - November 20, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

How Late Can You Give Routine Newborn Care?
Discussion Routine newborn screening and treatment is focused on assisting the infant’s transition to extrauterine life, screening for health problems that may or may not be easily identifiable, and preventing acute or chronic health problems. Healthy infants begin with healthy pregnancies including risk factor assessment and screening of mothers. Such routine maternal screening and treatment does or may include glucose tolerance tests, ultrasound examinations, screenings for maternal blood type (with appropriate administration of Rho(D) immunoglobulin if appropriate), Hepatitis B, Neisseria gonorrhea, Chlamydia, Cyt...
Source: PediatricEducation.org - November 20, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Roche launches automated serology hepatitis E virus tests, including a test to detect acute HEV infections, recommended in the new WHO 2023 Essential Diagnostics List
It is estimated that one third of the global population could be at risk for infection with Hepatitis E virus.1The new tests allow clinicians to diagnose acute and chronic infections amongst patients presenting with or without signs of the illness as recommended by the European Association for the Study of the Liver (EASL).2The tests complete Roche ’s panel used for the differential diagnosis of acute viral hepatitis caused by the hepatitis A, B, C and E viruses.Basel, 16 November 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the Elecsys ®Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays for t...
Source: Roche Investor Update - November 16, 2023 Category: Pharmaceuticals Source Type: news

Roche launches automated serology hepatitis E virus tests, including a test to detect acute HEV infections, recommended in the new WHO 2023 Essential Diagnostics List
It is estimated that one third of the global population could be at risk for infection with Hepatitis E virus.1The new tests allow clinicians to diagnose acute and chronic infections amongst patients presenting with or without signs of the illness as recommended by the European Association for the Study of the Liver (EASL).2The tests complete Roche ’s panel used for the differential diagnosis of acute viral hepatitis caused by the hepatitis A, B, C and E viruses.Basel, 16 November 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the Elecsys ®Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays for t...
Source: Roche Media News - November 16, 2023 Category: Pharmaceuticals Source Type: news

Increase in Hepatitis A Vaccination Needed to Prevent Deaths
WEDNESDAY, Oct. 25, 2023 -- Nearly two-thirds of those with hepatitis A virus (HAV)-related deaths have at least one documented indication for HAV vaccine, and only 4 percent have evidence of vaccination, according to research published in the Oct.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 25, 2023 Category: Pharmaceuticals Source Type: news

How COVID-19 Changed Life for People Terrified of Needles
From the moment COVID-19 reached pandemic designation, Joe McDougall had nightmares. Not, like others, about the potential path of the virus, but about the seemingly inevitable moment at which he’d be asked—or held down and forced—to receive a vaccine. McDougall, now 39, is terrified of needles and a global pandemic meant that for the first time since adolescence, he might not be able to avoid them.  [time-brightcove not-tgx=”true”] Of all of the challenges facing mass COVID-19 vaccination, fear of needles is one of the least acknowledged by public-health campaigns. Even what we know ...
Source: TIME: Health - October 12, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Source Type: news

Egypt becomes the first country to achieve WHO validation on the path to elimination of ...
9 October 2023, Cairo, Egypt – The World Health Organization (WHO) congratulates Egypt for its unprecedented progress towards eliminating hepatitis C, becoming the first country to achieve “gold tier” status on the path to elimination of hepatitis C as per WHO criteria. Achieving the gold tier means that Egypt has fulfilled the programmatic requirements that facilitate the reduction of new hepatitis C infections and deaths to levels that position the country to end the hepatitis C epidemic. Globally, 58 million people are living with chronic hepatitis C infection. While there is no vaccine, the disease can be cured ...
Source: WHO EMRO News - October 9, 2023 Category: Middle East Health Source Type: news